Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5419]
News [12581]
Articles [170]
Editorials [5]
Conferences [246]
elearning [17]
Putting drugs to work against brain metastases in HER2 positive breast cancer:...
Dr Thomas Bachelot – Centre Leon Berard, Lyon
Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study ( Dr Thomas Bachelot – Centre Leon Berard, Lyon )
4 Oct 2012
The Multinational Association of Supportive Care in Cancer (MASCC)
Dr Stephen Grunberg – University of Vermont, Burlington, USA
The Multinational Association of Supportive Care in Cancer (MASCC) ( Dr Stephen Grunberg – University of Vermont, Burlington, USA )
4 Oct 2012
Defining personalised medicine and patient empowerment
Prof Gabriella Pravettoni – University of Milan, Italy
Defining personalised medicine and patient empowerment ( Prof Gabriella Pravettoni – University of Milan, Italy )
4 Oct 2012
Phase I study examining PI 3 kinase inhibitor for various tumours
Dr Pamela Munster – University of California, San Francisco, USA
Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )
4 Oct 2012
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK...
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
30 Sep 2012
A proof-of-concept study of ODM-201 in patients with progressive castration...
Dr Christophe Massard - Institute Gustave Roussy, Paris, France
A proof-of-concept study of ODM-201 in patients with progressive castration-resistant prostate cancer ( Dr Christophe Massard - Institute Gustave Roussy, Paris, France )
30 Sep 2012
Too few women being offered breast-conserving treatment?
Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy
Too few women being offered breast-conserving treatment? ( Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy )
30 Sep 2012
Awareness of personalised medicine in cancer patients
Dr Sabine Tejpar - University Hospital Gasthuisberg, Lueven, Belgium
Awareness of personalised medicine in cancer patients ( Dr Sabine Tejpar - University Hospital Gasthuisberg, Lueven, Belgium )
30 Sep 2012
Phase I and II trials focus on drug combination slowing development of...
Prof Yossef Yarden - Weizmann Institute of Science, Israel.
Phase I and II trials focus on drug combination slowing development of resistance inhibiting BRAF ( Prof Yossef Yarden - Weizmann Institute of Science, Israel. )
29 Sep 2012
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib
Dr Tony Mok - Chinese University of Hong Kong
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib ( Dr Tony Mok - Chinese University of Hong Kong )
29 Sep 2012
Sorafenib does not extend overall survival as third or fourth line therapy in...
Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial ( Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain )
29 Sep 2012
Highlights from the 17th International Conference on Cancer Nursing
Greta Cummings – President of the International Society of Nurses of Cancer Care
Highlights from the 17th International Conference on Cancer Nursing ( Greta Cummings – President of the International Society of Nurses of Cancer Care )
21 Sep 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation